QAF (Q01) H2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2025 earnings summary
4 Nov, 2026Executive summary
FY2025 revenue was $633.6m, marginally below $636.1m; attributable profit rose 15% to $39.8m, supported by improved EBITDA and a non-cash joint-venture impairment reversal.
A $191m net cash position and proposed total FY2025 dividends of $0.05 per share support financial resilience and continued shareholder distributions.
Financial highlights
Revenue was $633.6m vs $636.1m; excluding FX effects, revenue increased 1% in constant-currency terms.
EBITDA before exceptional items rose 17% to $69.7m; EBITDA margin increased to 11.0% from 9.4%.
PBT after exceptional items increased 7% to $47.8m; PAT rose 16% to $40.3m and PATMI rose to $39.8m from $34.7m.
FY2025 had no exceptional items, versus $6.4m exceptional income in FY2024; FY2025 also included a $0.7m FX translation gain versus an $8.8m loss.
Operating cash flow was $53.2m vs $65.3m; cash and cash equivalents ended the year at $214.1m.
Outlook and guidance
2026 outlook remains uncertain amid early-year geopolitical events; priorities include product-mix adaptation, new products, distribution-channel expansion and export-market growth.
Singapore bakery plans more specialty loaves and single-serve buns, targeted value-oriented marketing and expansion into complementary food categories.
Australian bakery plans to accelerate retail and tourism channels, pursue New Zealand exports and continue product innovation; Philippine growth is expected to be more moderate than in prior years.
FY2030 resource targets: reduce energy consumption per metric tonne of sales volume by 4.5% and mobile fuel consumption per metric tonne by 1%, against FY2023 baselines.
Latest events from QAF
- Revenue grew 9%, but inflation and JV impairment tempered earnings momentum.Q01
H2 2023 - H1 PAT rose 150% as bakery recovery lifted adjusted earnings.Q01
H1 2024 - Profitability rebounded strongly, but consumer pressure and trade risks persist.Q01
H2 2024 - Flat constant-currency revenue, but sharply lower earnings amid cost, FX and impairment pressures.Q01
H1 2025 - Adjusted PBT rose 96%, but relocation costs and JV impairment cut H1 PATMI 51%.Q01
H1 2026